168 related articles for article (PubMed ID: 24724413)
1. [Angioimmunoblastic T-cell lymphoma].
Izutsu K
Nihon Rinsho; 2014 Mar; 72(3):519-23. PubMed ID: 24724413
[TBL] [Abstract][Full Text] [Related]
2. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.
Schetelig J; Fetscher S; Reichle A; Berdel WE; Beguin Y; Brunet S; Caballero D; Majolino I; Hagberg H; Johnsen HE; Kimby E; Montserrat E; Stewart D; Copplestone A; Rösler W; Pavel J; Kingreen D; Siegert W
Haematologica; 2003 Nov; 88(11):1272-8. PubMed ID: 14607756
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma.
Mohammed Saleh MF; Kotb A; Abdallah GEM; Muhsen IN; El Fakih R; Aljurf M
Curr Oncol; 2021 Dec; 28(6):5480-5498. PubMed ID: 34940095
[TBL] [Abstract][Full Text] [Related]
4. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Hosing C; Nieto YL; Oki Y
Br J Haematol; 2017 Mar; 176(5):750-758. PubMed ID: 27983760
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological analysis of patients with angioimmunoblastic T-cell lymphoma (AILT)].
Saito A; Miyazawa Y; Isoda A; Hatsumi N; Matsumoto M; Kojima M; Sawamura M
Rinsho Ketsueki; 2008 Feb; 49(2):82-8. PubMed ID: 18341037
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine treatment of angioimmunoblastic T-cell lymphoma relapsed after an autologous hematopoietic stem cell transplant.
Wang X; Zhang D; Wang L; Huang J; Yang Z; Wang J; Chen J; Liu L
Exp Clin Transplant; 2015 Apr; 13(2):203-5. PubMed ID: 24918480
[TBL] [Abstract][Full Text] [Related]
7. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.
Rodríguez J; Conde E; Gutiérrez A; Arranz R; Gandarillas M; Leon A; Ojanguren J; Sureda A; Carrera D; Bendandi M; Moraleda J; Ribera JM; Albo C; Morales A; García JC; Fernández P; Cañigral G; Bergua J; Caballero MD;
Eur J Haematol; 2007 Apr; 78(4):290-6. PubMed ID: 17378891
[TBL] [Abstract][Full Text] [Related]
8. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
[TBL] [Abstract][Full Text] [Related]
9. [Angioimmunoblastic T-cell lymphoma as a very poor-prognosis malignancy--a single centre experience].
Vokurka S; Koza V; Vozobulová V; Jindra P; Steinerová K; Schützová M; Boudová L
Klin Onkol; 2012; 25(3):206-11. PubMed ID: 22724570
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic efficacy of cyclosporin A for refractory angioimmunoblastic T cell lymphoma].
Mori M; Inoue D; Arima H; Takiuchi Y; Nagano S; Kimura T; Shimoji S; Nagai Y; Tabata S; Yanagita S; Matsushita A; Nagai K; Imai Y; Takahashi T
Rinsho Ketsueki; 2010 May; 51(5):332-8. PubMed ID: 20534954
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experience.
Lin HN; Liu CY; Hong YC; Pai JT; Yang CF; Yu YB; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Tzeng CH; Chen PM
Leuk Lymphoma; 2010 Dec; 51(12):2208-14. PubMed ID: 21054150
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of angioimmunoblastic T-cell lymphoma].
Tobinai K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():525-30. PubMed ID: 23134010
[No Abstract] [Full Text] [Related]
13. Cyclosporine A and reduced-intensity conditioning allogeneic stem cell transplantation for relapsed angioimmunoblastic T cell lymphoma with hemophagocytic syndrome.
Matsumura Y; Kuroda J; Shimura Y; Kiyota M; Yamamoto-Sugitani M; Kobayashi T; Matsumoto Y; Horiike S; Taniwaki M
Intern Med; 2012; 51(19):2785-7. PubMed ID: 23037475
[TBL] [Abstract][Full Text] [Related]
14. Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategies.
Alizadeh AA; Advani RH
Clin Adv Hematol Oncol; 2008 Dec; 6(12):899-909. PubMed ID: 19209140
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
Advani RH; Skrypets T; Civallero M; Spinner MA; Manni M; Kim WS; Shustov AR; Horwitz SM; Hitz F; Cabrera ME; Dlouhy I; Vassallo J; Pileri SA; Inghirami G; Montoto S; Vitolo U; Radford J; Vose JM; Federico M
Blood; 2021 Jul; 138(3):213-220. PubMed ID: 34292324
[TBL] [Abstract][Full Text] [Related]
16. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.
Lunning MA; Vose JM
Blood; 2017 Mar; 129(9):1095-1102. PubMed ID: 28115369
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with mogamulizumab of refractory/relapsed angioimmunoblastic T-cell lymphoma following autologous stem cell transplantation.
Oka S; Ono K; Nohgawa M
Leuk Lymphoma; 2019 Jun; 60(6):1595-1597. PubMed ID: 30732495
[No Abstract] [Full Text] [Related]
18. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
[TBL] [Abstract][Full Text] [Related]
19. Therapy refractory angioimmunoblastic T-cell lymphoma in complete remission with lenalidomide.
Beckers MM; Huls G
Eur J Haematol; 2013 Feb; 90(2):162-3. PubMed ID: 23227803
[TBL] [Abstract][Full Text] [Related]
20. Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma.
Crickx E; Poullot E; Moulis G; Goulabchand R; Fieschi C; Galicier L; Meignin V; Coppo P; Delarue R; Casasnovas O; Roos-Weil D; de Leval L; Parrens M; Michel M; Dupuis J; Le Bras F; Fataccioli V; Martin-Garcia N; Godeau B; Haïoun C; Gaulard P; Mahévas M
Eur J Haematol; 2019 Jul; 103(1):35-42. PubMed ID: 30985955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
